INSP vs. ROM

Last updated Jun 4, 2026

INSP (Inspire Medical Systems, Inc.) is a stock, while ROM (ProShares Ultra Technology) is Leveraged Equities fund tracking the Dow Jones U.S. Technology Index (200%). Over the past 5 years, INSP returned -24.51%/yr vs 31.70%/yr for ROM. At a 0.38 correlation, their price movements are largely independent.

Performance

INSP vs. ROM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Inspire Medical Systems, Inc. (INSP) and ProShares Ultra Technology (ROM). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, INSP achieves a -56.15% return, which is significantly lower than ROM's 77.72% return.

INSP

• 1D: -0.34%
• 1M: -26.26%
• YTD: -56.15%
• 6M: -69.99%
• 1Y: -70.77%
• 3Y*: -49.27%
• 5Y*: -24.51%
• 10Y*: —

ROM

• 1D: -2.01%
• 1M: 45.36%
• YTD: 77.72%
• 6M: 74.45%
• 1Y: 152.07%
• 3Y*: 59.24%
• 5Y*: 31.70%
• 10Y*: 42.70%

*Multi-year figures are annualized to reflect compound growth (CAGR)

INSP vs. ROM - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018
INSP Inspire Medical Systems, Inc.	-56.15%	-50.25%	-8.87%	-19.24%	9.48%	22.31%	153.46%	75.64%	69.14%
ROM ProShares Ultra Technology	77.72%	35.63%	31.65%	130.70%	-63.86%	77.75%	80.42%	102.10%	-16.25%

Correlation

The correlation between INSP and ROM is 0.11, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.11
Correlation (3Y) Calculated over the trailing 3-year period	0.23
Correlation (5Y) Calculated over the trailing 5-year period	0.37
Correlation (All Time) Calculated using the full available price history since May 4, 2018	0.38

Over the past year, the correlation between INSP and ROM has dropped to 0.11 - well below their long-term average of 0.38, suggesting their price drivers have been diverging.

Return for Risk

INSP vs. ROM — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

INSP

INSP Risk / Return Rank: 4
INSP Sharpe Ratio Rank: 6
INSP Sortino Ratio Rank: 4
INSP Omega Ratio Rank: 4
INSP Calmar Ratio Rank: 2
INSP Martin Ratio Rank: 4

ROM

ROM Risk / Return Rank: 83
ROM Sharpe Ratio Rank: 94
ROM Sortino Ratio Rank: 81
ROM Omega Ratio Rank: 80
ROM Calmar Ratio Rank: 85
ROM Martin Ratio Rank: 75

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

INSP vs. ROM - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Inspire Medical Systems, Inc. (INSP) and ProShares Ultra Technology (ROM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	INSP	ROM	Difference
Sharpe ratio: Return per unit of total volatility	-0.95	3.66	-4.62
Sortino ratio: Return per unit of downside risk	-1.65	3.69	-5.34
Omega ratio: Gain probability vs. loss probability	0.77	1.48	-0.72
Calmar ratio: Return relative to maximum drawdown	-0.98	4.73	-5.72
Martin ratio: Return relative to average drawdown	-1.58	14.47	-16.05
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

INSP vs. ROM - Sharpe Ratio Comparison

The current INSP Sharpe Ratio is -0.95, which is lower than the ROM Sharpe Ratio of 3.66. The chart below compares the historical Sharpe Ratios of INSP and ROM, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	INSP	ROM	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.95	3.66	-4.62
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.41	0.62	-1.03
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.86	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.10	0.54	-0.44

Drawdowns

INSP vs. ROM - Drawdown Comparison

The maximum INSP drawdown since its inception was -87.72%, which is greater than ROM's maximum drawdown of -83.36%. Use the drawdown chart below to compare losses from any high point for INSP and ROM.

Drawdown Indicators

	INSP	ROM	Difference
Max Drawdown Largest peak-to-trough decline	-87.72%	-83.36%	-4.36%
Max Drawdown (1Y) Largest decline over 1 year	-72.19%	-32.33%	-39.86%
Max Drawdown (3Y) Largest decline over 3 years	-87.72%	-48.10%	-39.62%
Max Drawdown (5Y) Largest decline over 5 years	-87.72%	-67.55%	-20.17%
Max Drawdown (10Y) Largest decline over 10 years	—	-67.55%	—
Current Drawdown Current decline from peak	-87.60%	-2.01%	-85.59%
Average Drawdown Average peak-to-trough decline	-27.58%	-20.88%	-6.70%
Ulcer Index Depth and duration of drawdowns from previous peaks	44.74%	10.55%	+34.19%

Volatility

INSP vs. ROM - Volatility Comparison

Inspire Medical Systems, Inc. (INSP) has a higher volatility of 18.19% compared to ProShares Ultra Technology (ROM) at 14.00%. This indicates that INSP's price experiences larger fluctuations and is considered to be riskier than ROM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	INSP	ROM	Difference
Volatility (1M) Calculated over the trailing 1-month period	18.19%	14.00%	+4.19%
Volatility (6M) Calculated over the trailing 6-month period	48.31%	33.37%	+14.94%
Volatility (1Y) Calculated over the trailing 1-year period	74.63%	41.83%	+32.80%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	60.37%	51.63%	+8.74%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	60.61%	49.82%	+10.79%

Dividends

INSP vs. ROM - Dividend Comparison

INSP has not paid dividends to shareholders, while ROM's dividend yield for the trailing twelve months is around 0.14%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
INSP Inspire Medical Systems, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
ROM ProShares Ultra Technology	0.14%	0.24%	0.21%	0.01%	0.00%	0.00%	0.05%	0.16%	0.30%	0.08%	0.20%	0.12%

Frequently Asked Questions

Can I hold both INSP and ROM in my portfolio?

INSP and ROM have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, INSP or ROM?

INSP has higher volatility (18.19%) compared to ROM (14.00%). In terms of maximum drawdown, INSP dropped -87.72% vs ROM's -83.36%.

Which has better risk-adjusted returns?

ROM currently has the higher Sharpe Ratio (3.66 vs -0.95), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.